ATE138571T1 - Verwendung von dioxabicyclo (3.3.0>octane derivaten zur herstellung eines arzneimittels zur hemmung des cholesterinmetabolismus. - Google Patents

Verwendung von dioxabicyclo (3.3.0>octane derivaten zur herstellung eines arzneimittels zur hemmung des cholesterinmetabolismus.

Info

Publication number
ATE138571T1
ATE138571T1 AT91309685T AT91309685T ATE138571T1 AT E138571 T1 ATE138571 T1 AT E138571T1 AT 91309685 T AT91309685 T AT 91309685T AT 91309685 T AT91309685 T AT 91309685T AT E138571 T1 ATE138571 T1 AT E138571T1
Authority
AT
Austria
Prior art keywords
dioxabicyclo
drug
production
cholesterol metabolism
inhibiting cholesterol
Prior art date
Application number
AT91309685T
Other languages
English (en)
Inventor
Kengo Akimoto
Sumio Asami
Michihiro Sugano
Nobuaki Hirose
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17644733&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE138571(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of ATE138571T1 publication Critical patent/ATE138571T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT91309685T 1990-10-22 1991-10-21 Verwendung von dioxabicyclo (3.3.0>octane derivaten zur herstellung eines arzneimittels zur hemmung des cholesterinmetabolismus. ATE138571T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28183990A JP3183664B2 (ja) 1990-10-22 1990-10-22 コレステロール及び胆汁酸の代謝阻害剤

Publications (1)

Publication Number Publication Date
ATE138571T1 true ATE138571T1 (de) 1996-06-15

Family

ID=17644733

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91309685T ATE138571T1 (de) 1990-10-22 1991-10-21 Verwendung von dioxabicyclo (3.3.0>octane derivaten zur herstellung eines arzneimittels zur hemmung des cholesterinmetabolismus.

Country Status (9)

Country Link
US (1) US5270335A (de)
EP (1) EP0488513B1 (de)
JP (1) JP3183664B2 (de)
AT (1) ATE138571T1 (de)
CA (1) CA2053820C (de)
DE (1) DE69119875T2 (de)
DK (1) DK0488513T3 (de)
ES (1) ES2087252T3 (de)
GR (1) GR3020682T3 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3283274B2 (ja) * 1991-06-15 2002-05-20 サントリー株式会社 新規組成物
JPH06227977A (ja) * 1993-02-01 1994-08-16 Suntory Ltd 活性酸素消去剤
US5397778A (en) * 1994-02-25 1995-03-14 New England Deaconess Hospital Corporation Enteral formulations for treatment of inflammation and infection
CA2183637A1 (en) * 1994-02-25 1995-08-31 R. Armour Forse Anti-inflammatory and infection protective effects of sesamin-based lignans
JP3818680B2 (ja) * 1994-05-12 2006-09-06 サントリー株式会社 アレルギー症状の予防又は改善剤
US5948451A (en) * 1995-07-04 1999-09-07 Suntory Limited Method of modifying the balance of omega unsaturated fatty acids using a dioxabicyclo octane derivative
JPH11246427A (ja) * 1998-03-04 1999-09-14 Kadoya Sesami Mills Inc 糖・脂質代謝活性化剤
KR100352269B1 (ko) * 1999-10-08 2002-09-12 한국생명공학연구원 저밀도 지질 단백질에 대해 항산화 활성을 갖는 리그난계 화합물
JP4388248B2 (ja) * 2001-10-29 2009-12-24 株式会社日立製作所 最適ポートフォリオ決定方法および装置
US7081260B2 (en) * 2002-10-29 2006-07-25 Council Of Scientific And Industrial Research α-Glucosidase inhibitors from a natural source
WO2006106926A1 (ja) * 2005-03-31 2006-10-12 Suntory Limited リグナン類化合物含有水中油滴型エマルション及びそれを含有する組成物
MY147736A (en) 2005-09-30 2013-01-15 Suntory Holdings Ltd A process and an apparatus for producing episesamin-rich compositions
WO2007114013A1 (ja) 2006-03-31 2007-10-11 Suntory Limited リグナン類化合物含有組成物
KR101425241B1 (ko) 2006-10-04 2014-08-01 산토리 홀딩스 가부시키가이샤 리그난류 화합물 함유 ｏ/ｗ/ｏ형 에멀션 및 그것을 함유하는 조성물
JP5051878B2 (ja) * 2007-03-02 2012-10-17 竹本油脂株式会社 高濃度セサミノール含有物の製造方法
CN101868238B (zh) 2007-09-19 2012-05-23 三得利控股株式会社 配合有芝麻素类和维生素b1类的组合物
JP7366991B2 (ja) * 2019-02-28 2023-10-23 株式会社えがお 体重増加抑制・低減用組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG42967A1 (en) * 1989-07-21 1997-10-17 Suntory Ltd Liver function improver

Also Published As

Publication number Publication date
JPH04159221A (ja) 1992-06-02
DE69119875T2 (de) 1996-10-02
EP0488513A2 (de) 1992-06-03
JP3183664B2 (ja) 2001-07-09
DK0488513T3 (da) 1996-06-17
EP0488513A3 (de) 1992-06-17
EP0488513B1 (de) 1996-05-29
CA2053820C (en) 1997-02-04
GR3020682T3 (en) 1996-10-31
ES2087252T3 (es) 1996-07-16
CA2053820A1 (en) 1992-04-23
US5270335A (en) 1993-12-14
DE69119875D1 (de) 1996-07-04

Similar Documents

Publication Publication Date Title
ATE138571T1 (de) Verwendung von dioxabicyclo (3.3.0>octane derivaten zur herstellung eines arzneimittels zur hemmung des cholesterinmetabolismus.
AU6128590A (en) Novel compounds
FI92399B (fi) Menetelmä lääkeaineena käyttökelpoisen tiatsolidinonin johdannaisen valmistamiseksi
DK444685D0 (da) Tiazolidindionderivater, farmaceutiske praeparater indeholdende dem ogfremgangsmaader til fremstilling deraf
AU6129890A (en) Novel compounds
DE69230958D1 (de) Arzneizusammensetzung auf Basis von Dioxabicyclo[3.3.0]octanderivaten
IL102093A0 (en) 1-methylcarbapenem derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same
IE893653L (en) Compositions and compounds
ATE60763T1 (de) Pyrrolidinylamidesterderivate mit antiprolylendopeptidaseaktivitaet, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische zubereitungen.
AU3381389A (en) Derivative of caffeic acid and pharmaceutical composition containing the same
LV10235A (lv) Jauni esteri to iegusanas panemiens farmaceitiska kompozicija arstesanas metode
KR860008973A (ko) 2-피롤리돈 유도체
HUT39448A (en) Process for producing 1,6-naphtiridine derivatives and pharmaceutical compositions containing them
BG101501A (en) Nitro-benzamides useful as anti-arrhytmic agents
ATE148128T1 (de) Anthracyclinglycosid-derivate und verfahren zu ihrer herstellung
DE69533298D1 (de) Dioxabicyclo 3.3.0 octan-Derivate, z.B. Sesamin etc., zur Vorbeugung und Erleichterung von Allergiesymptomen
DE68924991D1 (de) 2-Pyranon-Derivat und Verfahren zu dessen Herstellung.
MY107827A (en) Isoquinolline compounds, compositions and use
ATE125256T1 (de) Zwischenprodukte der mureidomycin-gruppe, ihre herstellung und verwendung.
ATE36154T1 (de) 4-phenylaminopyridin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
EP0441116A3 (en) Optically active chroman derivatives and intermediates thereof, and process for manufacturing same
DE69214180D1 (de) Verwendung von Bis-(p-Hydroxyphenylthio)methanderivaten zur Hemmung der fortschreitenden Entwicklung von insulinabhängingem Diabetes mellitus
HUT47929A (en) Process for producing 4-piperidine-carboxamide derivatives and pharmaceuticals comprising same
ATE186907T1 (de) Optisch aktives 1-phenylpyrrolidonderivat und dessen herstellung
AU4340793A (en) Benzopyran derivative, production thereof, and pharmaceutical preparation containing the same as active ingredient

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee